REQUEST A DEMO
Total
USD $0.00
Search more companies

Ardi Farma Ilac Pazarlama Ticaret Ltd. Sti. (Turkiye)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Ardi Farma Ilac Pazarlama Ticaret Limited Sirketi Profile Updated: March 05, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Ardi Farma Ilac Pazarlama Ticaret Ltd. Sti. is a company in Turkiye, with a head office in Istanbul. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The company was established on July 31, 2012. It currently has a total number of 2 (2026) employees. There was a net sales revenue increase of 18.43% reported in Ardi Farma Ilac Pazarlama Ticaret Ltd. Sti.’s latest financial highlights for 2024. Over the same period, its total assets grew by 260.1%. In 2024, Ardi Farma Ilac Pazarlama Ticaret Ltd. Sti.’s net profit margin increased by 23.61%.

Headquarters
Teknopark A1 D:222 No:1-1a Sanayi Mahallesi Teknopark Bulvari Pendik
Istanbul; Marmara; Postal Code: 34906

Contact Details: Purchase the Ardi Farma Ilac Pazarlama Ticaret Ltd. Sti. report to view the information.

Website: http://www.ardifarma.com

Basic Information
Total Employees:
Purchase the Ardi Farma Ilac Pazarlama Ticaret Ltd. Sti. report to view the information.
Financial Auditors:
Purchase the Ardi Farma Ilac Pazarlama Ticaret Ltd. Sti. report to view the information.
Incorporation Date:
July 31, 2012
Key Executives
Purchase this report to view the information.
Company Manager
Company Performance
Financial values in the chart are available after Ardi Farma Ilac Pazarlama Ticaret Ltd. Sti. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TRY. Absolute financial data is included in the purchased report.
Net sales revenue
18.43%
Total Operating Revenue
18.43%
Operating Profit
459.17%
Net Profit/Loss for the Period
457.02%
Total Assets
260.1%
Total Equity
357.15%
Operating Profit Margin
23.72%
Net Profit Margin
23.61%
Return on Equity (ROE)
13.37%
Debt / Equity
20.25%
Quick Ratio
-0.81%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?